Načítá se...
P08.58 Upfront chemotherapy in grade III gliomas: an institutional retrospective series
INTRODUCTION: Grade III gliomas are diseases with different molecular features, therapeutic responses and prognosis. In the last decades, markers like 1p/19q codeletion, methylation of MGMT promoter, IDH1, ATRX and TERT mutations have been detected: up to date they are known to be prognostic factors...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5782686/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.191 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|